Panacea Index Logo

Command Palette

Search for a command to run...

Moderate intensity walking exercises reduce the body mass index and vascular inflammatory factors in postmenopausal women with obesity: a randomized controlled trial.

Scientific reports
January 1, 1970
Woo-Hyeon Son et al. (4 authors)
Randomized Controlled TrialJournal ArticleHuman StudyClinical
Study Details

Study Goal

The researchers aimed to investigate the effects of moderate-intensity walking on body composition, vascular inflammatory factors, and VEGF in postmenopausal women with obesity.

Results Summary

The study found that a 12-week walking program significantly reduced weight, BMI, body fat percentage, and inflammatory markers (hs-CRP, IL-6, TNF-α) in the exercise group, suggesting potential benefits for preventing CVD. VEGF levels showed a non-significant tendency to increase.

Population

Postmenopausal women with obesity (ages 68-72).

Effective Dosage

Moderate-intensity walking (specific frequency/duration not detailed in abstract).

Duration

12 weeks.

Interactions

None mentioned.

Extracted Claims (8)
InterventionDirectionEndpointPopulationDosageImpactClaim #
moderate intensity walking exercise program
decrease
weight
postmenopausal women with obesity
-
significantly decreased
#1
moderate intensity walking exercise program
decrease
body mass index
postmenopausal women with obesity
-
significantly decreased
#2
moderate intensity walking exercise program
decrease
percentage body fat
postmenopausal women with obesity
-
significantly decreased
#3
moderate intensity walking exercise program
decrease
high-sensitivity C-reactive protein
postmenopausal women with obesity
-
significantly decreased
#4
moderate intensity walking exercise program
decrease
interleukin-6
postmenopausal women with obesity
-
significantly decreased
#5
moderate intensity walking exercise program
decrease
tumor necrosis factor-α
postmenopausal women with obesity
-
significantly decreased
#6
moderate intensity walking exercise program
no change
VEGF levels
postmenopausal women with obesity
-
did not change significantly
#7
moderate intensity walking exercise program
increase
VEGF levels
participants that exercised
-
a tendency to increase was observed
#8
Abstract

Postmenopause, the secretion of female hormones changes, causing excessive fat accumulation in the body and leading to chronic inflammation, which increases the incidence of cardiovascular diseases (CVD). Walking is an easily accessible daily exercise and effective non-pharmacological treatment for reducing obesity and the incidence of CVD. The aim of this study was to investigate the effect of moderate intensity walking exercises on body composition, vascular inflammatory factors, and vascular endothelial growth factor (VEGF) in postmenopausal women with obesity. Twenty-six older postmenopausal women with obesity (ages 68-72) were randomly assigned to control (n = 12, BMI 26.06 ± 1.37) or exercise (n = 14, BMI 26.04 ± 1.94) groups. Following a 12-week moderate intensity walking exercise program, we measured the participants' body composition with an InBody S10 analyzer and assessed blood sera using enzyme-linked immunosorbent assays. There was a significant clustering by weight (p < 0.01), body mass index (p < 0.01), percentage body fat (p < 0.001), high-sensitivity C-reactive protein (p < 0.05), interleukin-6, and tumor necrosis factor-α (p < 0.05) being significantly decreased in the exercise group. Although VEGF levels did not change significantly, a tendency to increase was observed in participants that exercised. Our results indicate that walking exercise may help prevent CVD in postmenopausal women with obesity by reducing obesity and vascular inflammatory factors.

Medical Subject Headings (MeSH)
FemaleHumansBody Mass IndexVascular Endothelial Growth Factor APostmenopauseObesityExercise TherapyWalkingBody CompositionCardiovascular Diseases
Study Links
Quality Scores
Safety90
Efficacy85/10
Quality80/10
Citation Metrics
Total Citations8
Citations/Year4.0
Relative Citation Ratio1.73
NIH Percentile70%
Research Impact Scores
APT Score0.75
Weight Score1.63
Normalized Score0.86
Related Supplements